IBTK contributes to B-cell lymphomagenesis in Eμ-myc transgenic mice conferring resistance to apoptosis-Reference-Cited by-同舟云学术

IBTK contributes to B-cell lymphomagenesis in Eμ-myc transgenic mice conferring resistance to apoptosis

Published:2019-04 Issue:4 Volume:10 Page:
ISSN:2041-4889
Container-title:Cell Death & Disease
language:en
Short-container-title:Cell Death Dis

Author:

Vecchio Eleonora,Golino Gaetanina,Pisano Antonio,Albano Francesco,Falcone Cristina,Ceglia Simona,Iaccino Enrico,Mimmi Selena,Fiume Giuseppe,Giurato Giorgio,Britti Domenico,Scala Giuseppe,Quinto Ileana

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Cell Biology,Cellular and Molecular Neuroscience,Immunology

Link

http://www.nature.com/articles/s41419-019-1557-6.pdf

Reference57 articles.

1. Spatuzza, C. et al. Physical and functional characterization of the genetic locus of IBtk, an inhibitor of Bruton’s tyrosine kinase: evidence for three protein isoforms of IBtk. Nucleic Acids Res. 36, 4402–4416 (2008).

2. Pisano, A. et al. CRL3IBTK regulates the tumor suppressor Pdcd4 through ubiquitylation coupled to proteasomal degradation. J. Biol. Chem. 290, 13958–13971 (2015).

3. Pisano A. et al. Revisiting Bacterial Ubiquitin Ligase Effectors: Weapons for Host Exploitation. International Journal of Molecular Sciences 19, 3576 (2018).

4. Fiume, G. et al. IBTK differently modulates gene expression and RNA splicing in HeLa and K562 cells. Int. J. Mol. Sci. 17, pii: E1848 (2016).

5. Baird, T. D. et al. Selective mRNA translation during eIF2 phosphorylation induces expression of IBTKalpha. Mol. Biol. Cell 25, 1686–1697 (2014).

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring Myc puzzle: Insights into cancer, stem cell biology, and PPI networks;Gene;2024-07

2. mTORC1/S6K1 signaling promotes sustained oncogenic translation through modulating CRL3IBTK-mediated ubiquitination of eIF4A1 in cancer cells;eLife;2024-05-13

3. mTORC1/S6K1 signaling promotes sustained oncogenic translation through modulating CRL3IBTK-mediated non-degradative ubiquitination of eIF4A1;2024-05-09

4. Enhanced pro-apoptotic activity of rituximab through IBTK silencing in non-Hodgkin lymphoma B-cells;Frontiers in Oncology;2024-02-02

5. mTORC1/S6K1 signaling promotes sustained oncogenic translation through modulating CRL3IBTK-mediated non-degradative ubiquitination of eIF4A1;ELIFE;2023-12-05